Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes

https://doi.org/10.1016/j.ijcard.2023.05.004Get rights and content

Highlights

  • Pheochromocytoma-induced cardiogenic shock presents a fairly good mid-term prognosis with rapid improvement of left ventricle ejection fraction.

  • It should be suspected in case of Takotsubo-like myocardial injury progressing to cardiogenic shock or severe cyclic blood pressure fluctuation and rapid hemodynamic deterioration.

  • The main challenge is to stabilize the patient, with medical therapy or with temporary-mechanical circulatory support in most severe cases.

Abstract

Objective

There is still uncertainty about the management of patients with pheochromocytoma-induced cardiogenic shock (PICS). This study aims to investigate the clinical presentation, management, and outcome of patients with PICS.

Methods

We collected, retrospectively, the data of 18 patients without previously known pheochromocytoma admitted to 8 European hospitals with a diagnosis of PICS.

Results

Among the 18 patients with a median age of 50 years (Q1-Q3: 40–61), 50% were men. The main clinical features at presentation were pulmonary congestion (83%) and cyclic fluctuation of hypertension peaks and hypotension (72%). Echocardiography showed a median left ventricular ejection fraction (LVEF) of 25% (Q1-Q3: 15–33.5) with an atypical- Takotsubo (TTS) pattern in 50%. Inotropes/vasopressors were started in all patients and temporary mechanical circulatory support (t-MCS) was required in 11 (61%) patients. All patients underwent surgical removal of the pheochromocytoma; 4 patients (22%) were operated on while under t-MCS. The median LVEF was estimated at 55% at discharge. Only one patient required heart transplantation (5.5%), and all patients were alive at a median follow-up of 679 days.

Conclusions

PICS should be suspected in case of a CS with severe cyclic blood pressure fluctuation and rapid hemodynamic deterioration, associated with increased inflammatory markers or in case of TTS progressing to CS, particularly if an atypical TTS echocardiographic pattern is revealed.

T-MCS should be considered in the most severe cases. The main challenge is to stabilize the patient, with medical therapy or with t-MCS, since it remains a reversible cause of CS with a low mortality rate.

Graphical abstract

Unlabelled Image
  1. Download : Download high-res image (231KB)
  2. Download : Download full-size image

Graphical abstract: Pheochromocytoma-induced cardiogenic shock: a multicentre analysis of clinical profiles, management and outcomes.

Introduction

Pheochromocytoma is a rare catecholamine-secreting neuroendocrine tumor arising from chromaffin cells in the adrenal medulla with an age-standardized incidence rate of 0.46 per 100,000 person-years [1]. Due to its highly variable clinical picture and location in the body it may be confused with a number of other diseases, that's why it is often referred to as the “great imitator” [2]. The diagnosis can be established through the presentation of classic symptoms (persistent or paroxysmal hypertension, palpitations, headaches, diaphoresis, tremors, and/or anxiety), the detection of incidentaloma on routine imaging workup, like point-of-care ultrasound (POCUS) or abdominal computed tomography (CT) in the emergency department, routine biochemical screening, or a pheochromocytoma crisis [ [3], [4], [5]]. Cardiogenic shock (CS), as an expression of a pheochromocytoma crisis, can occur in about 2% of patients [6]. Chronic and acute catecholamine secretion can lead to structural myocardial damage which is the leading cause of morbidity and mortality in this population [7]. Pheochromocytoma crisis can occur spontaneously, because of tumor hemorrhage and/or necrosis leading to an abrupt release of catecholamine into the bloodstream, or can be precipitated by trauma or specific drugs (for instance beta-adrenergic blockers, tricyclic antidepressants, corticosteroids, metoclopramide) [8].

Patients with no history of pheochromocytoma presenting with CS and evidence of severe left ventricular (LV) systolic dysfunction may pose a significant challenge with regards to the diagnosis of pheochromocytoma-induced CS (PICS) [9].

There is still uncertainty over the management of PICS [10]. Literature is scarce and is only limited to case reports, data-limited retrospective studies and literature reviews [[11], [12], [13], [14]]. Our work aims to bring new insights into the diagnosis of PICS with regard to clinical presentations, hemodynamic profiles, echocardiographic findings, management, and outcome. We seek at raising awareness around this pathology while suggesting features that should prompt a search for pheochromocytoma in the presence of CS [8,9].

Section snippets

Methods

We retrospectively collected the data of 18 patients with PICS admitted to the Intensive Care Units (ICU) of 8 European hospitals between 2008 and December 2021. The coordinating center was the Louis Pradel Hospital of Lyon, France, and the other centers were Antwerp University Hospital, Belgium, University Hospital Ruggi d'Aragona, Salerno, Gemelli Hospital, Rome, Niguarda Hospital, Milan, University Hospital, Padua, University Maggiore Hospital, Parma, and University Hospital, Trieste all in

Results

The baseline characteristics are summarized in Table 1. Briefly, 9 patients (50%) were males and the median age was 50 years (Q1-Q3: 40–61). We identified a triggering factor for the CS in 8 cases (44.4%): two patients presented CS immediately after a surgical intervention, 2 patients after the administration of intramuscular drugs (corticosteroids and metoclopramide), 2 patients during a Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2) infection, one patient after an influenza

Discussion

We report, to our knowledge, the largest case series of PICS, detailing clinical presentations, electrocardiographic characteristics, echocardiographic features, hemodynamic profiles and management. Cardiac involvement has been reported in 30% of the subjects with pheochromocytoma with a few cases featuring CS as a first clinical expression [9,24].

Our work provides findings that should be considered when dealing with CS to avoid overlooking the diagnosis of PICS. As previously reported, the

Limitations

The results of this study need to be considered in light of some limitations. Firstly, the retrospective, observational design is associated with numerous sources of bias. Secondly, PICS is a rare event and our sample is therefore limited for a detailed statistical analysis, despite the multicentre recruitment. Thirdly, we provided limited histopathological data because of the rarity of the realization of myocardial biopsies in these patients. Fourthly, bio humoral tests have been carried out

Conclusion

Pheochromocytoma is an infrequent cause of CS, with many presentations and patterns, most often with TTS-like myocardial injury. It should be suspected in case of a CS with severe cyclic blood pressure fluctuation and rapid hemodynamic deterioration, associated with increased inflammatory markers; it may be reasonable to suggest a systematic screening for pheochromocytoma in every initially suspected TTS progressing to CS, particularly if an atypical TTS echocardiographic pattern is revealed.

We

Acknowledgements

The abstract with preliminary results of this study was presented at the 53nd ANMCO Congress, Rimini, Italy, 19th-21th May 2022 and published on the European Heart Journal Supplements Volume 24, May 2022, https://doi.org/10.1093/eurheartj/suac011.073.

References (39)

  • K. Negishi et al.

    Detection of adrenal mass during an educational point-of-care ultrasound in the emergency department

    World J Emerg Med

    (2021)
  • B.E. Bergland

    Pheochromocytoma presenting as shock

    Am. J. Emerg. Med.

    (1989)
  • X. Zhou et al.

    Pheochromocytoma crisis with severe cyclic blood pressure fluctuations in a cardiac pheochromocytoma patient successfully resuscitated by extracorporeal membrane oxygenation: a case report

    Med (United States)

    (2015)
  • E. Cornu et al.

    Acute stress cardiomyopathy: heart of pheochromocytoma

    Ann. Endocrinol. (Paris)

    (2020)
  • C. Lentschener et al.

    Point of controversy: perioperative care of patients undergoing pheochromocytoma removal-time for a reappraisal?

    Eur. J. Endocrinol.

    (2011)
  • G. Hekimian et al.

    Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock

    Ann. Intensive Care

    (2016)
  • B. Sauneuf et al.

    Pheochromocytoma crisis in the ICU: a French multicenter cohort study with emphasis on rescue extracorporeal membrane oxygenation

    Crit. Care Med.

    (2017)
  • A. Aw et al.

    A systematic cohort review of pheochromocytoma-induced typical versus atypical Takotsubo cardiomyopathy

    Int. J. Cardiol.

    (2023)
  • M. Matteucci et al.

    Extracorporeal life support for phaeochromocytoma-induced cardiogenic shock: a systematic review

    Perfus (United Kingdom)

    (2020)
  • View full text